Anifrolumab,cenerimod
Astrazeneca,idorsia pharmaceuticals
[]
the first session of our last full day at #acr22 is beginning with the sle - treatment asbstract session! both of our highlighted abstracts in this session are chairman's picks - 1652 and 1656. make sure to go and view and we'll see you there!
A free educational resource for anyone involved in lupus research and treatment. Guided by a global steering committee chaired by @EdVital.